Walgreens Boots Alliance Inc (WBA) Receives Consensus Recommendation of “Buy” from Analysts

Walgreens Boots Alliance Inc (NASDAQ:WBA) has been given an average rating of “Buy” by the twenty-three ratings firms that are presently covering the firm, MarketBeat.com reports. Ten investment analysts have rated the stock with a hold recommendation, twelve have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $84.47.

WBA has been the topic of a number of research analyst reports. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, November 10th. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Citigroup decreased their price objective on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, November 2nd. Finally, Leerink Swann cut Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st.

In other news, insider Stefano Pessina purchased 98,858 shares of the company’s stock in a transaction dated Monday, January 15th. The shares were acquired at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a filing with the SEC, which is available at this link. 14.80% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Sawtooth Solutions LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at about $376,000. We Are One Seven LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at about $869,000. HM Payson & Co. boosted its position in Walgreens Boots Alliance by 2.3% during the fourth quarter. HM Payson & Co. now owns 36,334 shares of the pharmacy operator’s stock valued at $2,638,000 after purchasing an additional 821 shares in the last quarter. Banco de Sabadell S.A bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at about $1,190,000. Finally, Altman Advisors Inc. bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at about $1,570,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded up $1.14 during trading hours on Wednesday, hitting $70.92. The company had a trading volume of 4,623,600 shares, compared to its average volume of 5,990,885. The company has a market cap of $70,258.24, a P/E ratio of 19.59, a PEG ratio of 1.19 and a beta of 1.18. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance has a 52 week low of $63.82 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same period in the previous year, the firm earned $1.10 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. research analysts predict that Walgreens Boots Alliance will post 5.73 EPS for the current year.

Walgreens Boots Alliance declared that its board has initiated a share repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s management believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.26%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 44.20%.

TRADEMARK VIOLATION WARNING: This news story was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://stocknewstimes.com/2018/02/19/walgreens-boots-alliance-inc-wba-receives-consensus-recommendation-of-buy-from-analysts.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply